How European AI Startups Raise in 2026: A Founder's Guide to Rounds, Investors, and Dilution

Seed Stage: What Normal Looks Like in 2026

A typical European AI seed round in 2026 sits between EUR 1.5 million and EUR 4 million, at a pre-money valuation of EUR 6 million to EUR 12 million. That puts founder dilution in the 15 to 25 per cent range per round, assuming a clean structure with no convertible notes layered on top. Index Ventures and Northzone, both of which publish regular commentary on European deal activity, have each signalled that they regard the EUR 2 to 3 million seed as the market-clearing size for an AI company with a working prototype and early design partners but no meaningful revenue.

The instruments matter here. The SAFE (Simple Agreement for Future Equity), imported from Y Combinator, has become common at the pre-seed stage across the UK, France, and the Nordic countries. But European lawyers frequently layer a discount rate and a valuation cap onto a SAFE at the same time, which creates a compound dilution effect at the priced round that founders consistently underestimate. If you take EUR 500,000 on a 20 per cent discount SAFE with a EUR 5 million cap, and your seed prices at EUR 10 million pre-money, the cap bites and your effective dilution from that pre-seed instrument is closer to 10 per cent, not 5. Model it before you sign.

Sifted's founder surveys from 2024 and 2025 found that dilution miscalculation at the pre-seed to seed transition was among the top three regrets cited by Series A-stage founders. The others were taking money from the wrong investor and raising too slowly in a rising-rate environment.

Series A: When the Dollar Takes Over

The inflection to US dollar denomination at Series A is not arbitrary. European AI companies targeting enterprise customers, particularly those building foundation-model infrastructure or vertical AI for regulated industries, find that American institutional investors, specifically those with exposure to similar US companies, insist on dollar-denominated instruments and Delaware or Cayman holding structures as a condition of participation. Index Ventures, which operates across both continents and has backed companies including Adyen and Figma, has been explicit in its public writing that European founders should expect to restructure their holding company before a Series A if they want access to the widest pool of capital.

A 2026 Series A for a European AI company with EUR 1 to 3 million in annual recurring revenue typically prices at USD 15 million to USD 35 million pre-money, with rounds of USD 8 million to USD 18 million. Northzone, whose portfolio includes Klarna and a growing number of AI-native companies, has been particularly active at this stage in the Nordic and Baltic markets, where deep-tech AI talent concentration has produced a cluster of enterprise software companies that fit the profile.

Founder dilution at Series A, accounting for the seed round already absorbed, commonly puts founders in the 45 to 60 per cent ownership range after two rounds, before any employee option pool. The option pool shuffle, a mechanism by which investors require the pool to be created pre-money rather than post-money, effectively transfers dilution onto founders rather than investors. On a USD 20 million pre-money valuation, creating a 15 per cent option pool pre-money reduces the effective pre-money to USD 17 million from the founder's perspective. This is not a scandal; it is standard practice. But it is frequently not explained clearly in term sheets, and Sifted's reporting has documented multiple cases where European founders discovered the effect only during legal review.

The Corporate Strategic: A New Force on the Cap Table

The most significant structural change to European AI fundraising since 2023 is the aggressive entry of large industrial and life-sciences corporates as strategic investors. Bosch, Sanofi, and Telefonica are the three clearest examples, each of which has formalised its AI investment activity and is now writing cheques at seed and Series A stages that would previously have been the exclusive domain of venture capital.

Bosch Ventures, the corporate venture arm of the Stuttgart-based engineering group, has publicly committed to AI investments in manufacturing, mobility, and building technology verticals. For a founder building in industrial AI, a Bosch strategic investment brings not just capital but a distribution channel into a EUR 90 billion-plus revenue corporation and its supplier network. The trade-off is real: corporates move slowly, their investment committees have strategic rather than purely financial mandates, and they can create complications if a competitor acquires you or if you pivot.

Sanofi, the French pharmaceutical group, launched its AI and data science investment programme with a stated focus on biotech and drug-discovery AI companies operating in Europe. Its involvement signals that life-sciences AI, arguably the most capital-intensive vertical in the sector, now has a dedicated European corporate backer willing to co-invest alongside specialist VCs such as Jeito Capital, the Paris-based life-sciences fund.

Telefonica's venture and innovation arm, Wayra, has been investing in European AI startups for over a decade, but its 2024 and 2025 cohorts shifted decisively toward AI-native companies rather than digital transformation plays. For founders building in telecoms infrastructure AI, security, or B2B SaaS with telecom customers, a Wayra relationship offers both capital and a shortcut to enterprise pilots in one of Europe's largest telecoms groups.

The practical advice for founders considering a corporate strategic is to negotiate information rights, pro-rata rights, and transfer restrictions with particular care. Many corporate term sheets include right-of-first-refusal clauses on secondary sales that can make it harder to bring in new investors at later rounds. Have a specialist venture lawyer, not a generalist corporate solicitor, review any strategic term sheet before you sign.

## By The Numbers

The following figures anchor the patterns described above in verifiable data from Atomico, Crunchbase, Sifted, and published investor commentary. They illustrate the scale of European AI investment, the typical deal parameters at each stage, and the ownership dynamics that determine whether a founder reaches Series B with meaningful equity intact.

Finding the Right Lead Investor by Stage

At pre-seed and seed, the European landscape has a clear tier of specialists. Balderton Capital, Seedcamp, and LocalGlobe in the UK; Kfund and Nauta Capital in Spain; Fly Ventures and UVC Partners in Germany; and Creandum across the Nordics all have active AI mandates and can lead or co-lead at the EUR 1 to 4 million seed level. Each publishes thesis documents and portfolio data that founders should read before making contact; cold outreach to a fund whose thesis your company does not match is a waste of everyone's time.

At Series A, the relevant set widens to include Index Ventures and Northzone as consistent European leads, alongside Accel's London and Stockholm offices and the European franchise of General Catalyst. American crossover funds, Andreessen Horowitz, Sequoia's Arc programme, and Lightspeed, are present but typically require a warm introduction from a European co-investor or a portfolio company reference.

Government-backed vehicles deserve more attention than most founders give them. The European Investment Fund co-invests alongside private VCs across the continent, and national equivalents, Bpifrance in France, KfW Capital in Germany, British Patient Capital in the UK (now operating under its successor structure) provide non-dilutive grants and loan instruments at the pre-seed stage that can reduce the amount of equity you need to sell. A EUR 250,000 Bpifrance innovation grant taken before a seed round is EUR 250,000 of dilution you did not have to absorb.

The Dilution Maths: A Worked Example

Consider a two-founder AI startup. They take EUR 150,000 from friends and family at incorporation, giving away 10 per cent. They raise EUR 500,000 on a SAFE with a EUR 5 million cap and 20 per cent discount. At a EUR 10 million pre-money seed, the cap applies: the SAFE converts as if the valuation were EUR 5 million, giving the pre-seed investor 10 per cent. The seed round of EUR 2.5 million at EUR 10 million pre-money gives new investors 20 per cent. After seed, founders hold approximately 56 per cent, the friends-and-family investor holds 10 per cent, the SAFE investor holds 10 per cent, and the seed fund holds 20 per cent. The option pool, if created pre-money at 10 per cent, has already been absorbed, reducing the effective founder share to around 50 per cent before Series A begins. A Series A of USD 12 million at USD 24 million pre-money takes 33 per cent. Founders exit Series A with roughly 33 per cent between them. That is not a disaster; it is roughly market. But founders who did not model the SAFE cap interaction are frequently surprised to find themselves here.